 | • レポートコード：MRC2-11QY07388 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はリソソームα-グルコシダーゼのグローバル市場について調査・分析したレポートです。種類別（AT-982、ATB-200、AVRRD-03、JR-162、MOSS-GAA、OXY-2810、その他）市場規模、用途別（糖原病、ポンペ病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別リソソームα-グルコシダーゼの競争状況、市場シェア ・世界のリソソームα-グルコシダーゼ市場：種類別市場規模 2015年-2020年（AT-982、ATB-200、AVRRD-03、JR-162、MOSS-GAA、OXY-2810、その他） ・世界のリソソームα-グルコシダーゼ市場：種類別市場規模予測 2021年-2026年（AT-982、ATB-200、AVRRD-03、JR-162、MOSS-GAA、OXY-2810、その他） ・世界のリソソームα-グルコシダーゼ市場：用途別市場規模 2015年-2020年（糖原病、ポンペ病、その他） ・世界のリソソームα-グルコシダーゼ市場：用途別市場規模予測 2021年-2026年（糖原病、ポンペ病、その他） ・北米のリソソームα-グルコシダーゼ市場分析：米国、カナダ ・ヨーロッパのリソソームα-グルコシダーゼ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのリソソームα-グルコシダーゼ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のリソソームα-グルコシダーゼ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのリソソームα-グルコシダーゼ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amicus Therapeutics Inc、Audentes Therapeutics Inc、Etubics Corp、Genzyme Corp、greenovation Biotech GmbH、Huons Co Ltd、JCR Pharmaceuticals Co Ltd、Oxyrane Belgium NV、Pharming Group NV、Sarepta Therapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Lysosomal Alpha Glucosidase Market
The global Lysosomal Alpha Glucosidase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Lysosomal Alpha Glucosidase Scope and Market Size
Lysosomal Alpha Glucosidase market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lysosomal Alpha Glucosidase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Lysosomal Alpha Glucosidase market is segmented into
AT-982
ATB-200
AVRRD-03
JR-162
MOSS-GAA
OXY-2810
Others
Segment by Application, the Lysosomal Alpha Glucosidase market is segmented into
Glycogen Storage Disease
Pompe Disease
Others
Regional and Country-level Analysis
The Lysosomal Alpha Glucosidase market is analysed and market size information is provided by regions (countries).
The key regions covered in the Lysosomal Alpha Glucosidase market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Lysosomal Alpha Glucosidase Market Share Analysis
Lysosomal Alpha Glucosidase market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Lysosomal Alpha Glucosidase business, the date to enter into the Lysosomal Alpha Glucosidase market, Lysosomal Alpha Glucosidase product introduction, recent developments, etc.
The major vendors covered:
Amicus Therapeutics Inc
Audentes Therapeutics Inc
Etubics Corp
Genzyme Corp
greenovation Biotech GmbH
Huons Co Ltd
JCR Pharmaceuticals Co Ltd
Oxyrane Belgium NV
Pharming Group NV
Sarepta Therapeutics Inc
1 Study Coverage
1.1 Lysosomal Alpha Glucosidase Product Introduction
1.2 Market Segments
1.3 Key Lysosomal Alpha Glucosidase Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Lysosomal Alpha Glucosidase Market Size Growth Rate by Type
1.4.2 AT-982
1.4.3 ATB-200
1.4.4 AVRRD-03
1.4.5 JR-162
1.4.6 MOSS-GAA
1.4.7 OXY-2810
1.4.8 Others
1.5 Market by Application
1.5.1 Global Lysosomal Alpha Glucosidase Market Size Growth Rate by Application
1.5.2 Glycogen Storage Disease
1.5.3 Pompe Disease
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Lysosomal Alpha Glucosidase Market Size, Estimates and Forecasts
2.1.1 Global Lysosomal Alpha Glucosidase Revenue 2015-2026
2.1.2 Global Lysosomal Alpha Glucosidase Sales 2015-2026
2.2 Global Lysosomal Alpha Glucosidase, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Lysosomal Alpha Glucosidase Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Lysosomal Alpha Glucosidase Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Lysosomal Alpha Glucosidase Competitor Landscape by Players
3.1 Lysosomal Alpha Glucosidase Sales by Manufacturers
3.1.1 Lysosomal Alpha Glucosidase Sales by Manufacturers (2015-2020)
3.1.2 Lysosomal Alpha Glucosidase Sales Market Share by Manufacturers (2015-2020)
3.2 Lysosomal Alpha Glucosidase Revenue by Manufacturers
3.2.1 Lysosomal Alpha Glucosidase Revenue by Manufacturers (2015-2020)
3.2.2 Lysosomal Alpha Glucosidase Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Lysosomal Alpha Glucosidase Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Lysosomal Alpha Glucosidase Revenue in 2019
3.2.5 Global Lysosomal Alpha Glucosidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Lysosomal Alpha Glucosidase Price by Manufacturers
3.4 Lysosomal Alpha Glucosidase Manufacturing Base Distribution, Product Types
3.4.1 Lysosomal Alpha Glucosidase Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Lysosomal Alpha Glucosidase Product Type
3.4.3 Date of International Manufacturers Enter into Lysosomal Alpha Glucosidase Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lysosomal Alpha Glucosidase Market Size by Type (2015-2020)
4.1.1 Global Lysosomal Alpha Glucosidase Sales by Type (2015-2020)
4.1.2 Global Lysosomal Alpha Glucosidase Revenue by Type (2015-2020)
4.1.3 Lysosomal Alpha Glucosidase Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Lysosomal Alpha Glucosidase Market Size Forecast by Type (2021-2026)
4.2.1 Global Lysosomal Alpha Glucosidase Sales Forecast by Type (2021-2026)
4.2.2 Global Lysosomal Alpha Glucosidase Revenue Forecast by Type (2021-2026)
4.2.3 Lysosomal Alpha Glucosidase Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Lysosomal Alpha Glucosidase Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Lysosomal Alpha Glucosidase Market Size by Application (2015-2020)
5.1.1 Global Lysosomal Alpha Glucosidase Sales by Application (2015-2020)
5.1.2 Global Lysosomal Alpha Glucosidase Revenue by Application (2015-2020)
5.1.3 Lysosomal Alpha Glucosidase Price by Application (2015-2020)
5.2 Lysosomal Alpha Glucosidase Market Size Forecast by Application (2021-2026)
5.2.1 Global Lysosomal Alpha Glucosidase Sales Forecast by Application (2021-2026)
5.2.2 Global Lysosomal Alpha Glucosidase Revenue Forecast by Application (2021-2026)
5.2.3 Global Lysosomal Alpha Glucosidase Price Forecast by Application (2021-2026)
6 North America
6.1 North America Lysosomal Alpha Glucosidase by Country
6.1.1 North America Lysosomal Alpha Glucosidase Sales by Country
6.1.2 North America Lysosomal Alpha Glucosidase Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Lysosomal Alpha Glucosidase Market Facts & Figures by Type
6.3 North America Lysosomal Alpha Glucosidase Market Facts & Figures by Application
7 Europe
7.1 Europe Lysosomal Alpha Glucosidase by Country
7.1.1 Europe Lysosomal Alpha Glucosidase Sales by Country
7.1.2 Europe Lysosomal Alpha Glucosidase Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Lysosomal Alpha Glucosidase Market Facts & Figures by Type
7.3 Europe Lysosomal Alpha Glucosidase Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Lysosomal Alpha Glucosidase by Region
8.1.1 Asia Pacific Lysosomal Alpha Glucosidase Sales by Region
8.1.2 Asia Pacific Lysosomal Alpha Glucosidase Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Lysosomal Alpha Glucosidase Market Facts & Figures by Type
8.3 Asia Pacific Lysosomal Alpha Glucosidase Market Facts & Figures by Application
9 Latin America
9.1 Latin America Lysosomal Alpha Glucosidase by Country
9.1.1 Latin America Lysosomal Alpha Glucosidase Sales by Country
9.1.2 Latin America Lysosomal Alpha Glucosidase Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Lysosomal Alpha Glucosidase Market Facts & Figures by Type
9.3 Central & South America Lysosomal Alpha Glucosidase Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Lysosomal Alpha Glucosidase by Country
10.1.1 Middle East and Africa Lysosomal Alpha Glucosidase Sales by Country
10.1.2 Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Lysosomal Alpha Glucosidase Market Facts & Figures by Type
10.3 Middle East and Africa Lysosomal Alpha Glucosidase Market Facts & Figures by Application
11 Company Profiles
11.1 Amicus Therapeutics Inc
11.1.1 Amicus Therapeutics Inc Corporation Information
11.1.2 Amicus Therapeutics Inc Description and Business Overview
11.1.3 Amicus Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Products Offered
11.1.5 Amicus Therapeutics Inc Related Developments
11.2 Audentes Therapeutics Inc
11.2.1 Audentes Therapeutics Inc Corporation Information
11.2.2 Audentes Therapeutics Inc Description and Business Overview
11.2.3 Audentes Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Products Offered
11.2.5 Audentes Therapeutics Inc Related Developments
11.3 Etubics Corp
11.3.1 Etubics Corp Corporation Information
11.3.2 Etubics Corp Description and Business Overview
11.3.3 Etubics Corp Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Etubics Corp Lysosomal Alpha Glucosidase Products Offered
11.3.5 Etubics Corp Related Developments
11.4 Genzyme Corp
11.4.1 Genzyme Corp Corporation Information
11.4.2 Genzyme Corp Description and Business Overview
11.4.3 Genzyme Corp Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Genzyme Corp Lysosomal Alpha Glucosidase Products Offered
11.4.5 Genzyme Corp Related Developments
11.5 greenovation Biotech GmbH
11.5.1 greenovation Biotech GmbH Corporation Information
11.5.2 greenovation Biotech GmbH Description and Business Overview
11.5.3 greenovation Biotech GmbH Sales, Revenue and Gross Margin (2015-2020)
11.5.4 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Products Offered
11.5.5 greenovation Biotech GmbH Related Developments
11.6 Huons Co Ltd
11.6.1 Huons Co Ltd Corporation Information
11.6.2 Huons Co Ltd Description and Business Overview
11.6.3 Huons Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Huons Co Ltd Lysosomal Alpha Glucosidase Products Offered
11.6.5 Huons Co Ltd Related Developments
11.7 JCR Pharmaceuticals Co Ltd
11.7.1 JCR Pharmaceuticals Co Ltd Corporation Information
11.7.2 JCR Pharmaceuticals Co Ltd Description and Business Overview
11.7.3 JCR Pharmaceuticals Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Products Offered
11.7.5 JCR Pharmaceuticals Co Ltd Related Developments
11.8 Oxyrane Belgium NV
11.8.1 Oxyrane Belgium NV Corporation Information
11.8.2 Oxyrane Belgium NV Description and Business Overview
11.8.3 Oxyrane Belgium NV Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Products Offered
11.8.5 Oxyrane Belgium NV Related Developments
11.9 Pharming Group NV
11.9.1 Pharming Group NV Corporation Information
11.9.2 Pharming Group NV Description and Business Overview
11.9.3 Pharming Group NV Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pharming Group NV Lysosomal Alpha Glucosidase Products Offered
11.9.5 Pharming Group NV Related Developments
11.10 Sarepta Therapeutics Inc
11.10.1 Sarepta Therapeutics Inc Corporation Information
11.10.2 Sarepta Therapeutics Inc Description and Business Overview
11.10.3 Sarepta Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Products Offered
11.10.5 Sarepta Therapeutics Inc Related Developments
11.1 Amicus Therapeutics Inc
11.1.1 Amicus Therapeutics Inc Corporation Information
11.1.2 Amicus Therapeutics Inc Description and Business Overview
11.1.3 Amicus Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Products Offered
11.1.5 Amicus Therapeutics Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Lysosomal Alpha Glucosidase Market Estimates and Projections by Region
12.1.1 Global Lysosomal Alpha Glucosidase Sales Forecast by Regions 2021-2026
12.1.2 Global Lysosomal Alpha Glucosidase Revenue Forecast by Regions 2021-2026
12.2 North America Lysosomal Alpha Glucosidase Market Size Forecast (2021-2026)
12.2.1 North America: Lysosomal Alpha Glucosidase Sales Forecast (2021-2026)
12.2.2 North America: Lysosomal Alpha Glucosidase Revenue Forecast (2021-2026)
12.2.3 North America: Lysosomal Alpha Glucosidase Market Size Forecast by Country (2021-2026)
12.3 Europe Lysosomal Alpha Glucosidase Market Size Forecast (2021-2026)
12.3.1 Europe: Lysosomal Alpha Glucosidase Sales Forecast (2021-2026)
12.3.2 Europe: Lysosomal Alpha Glucosidase Revenue Forecast (2021-2026)
12.3.3 Europe: Lysosomal Alpha Glucosidase Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Lysosomal Alpha Glucosidase Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Lysosomal Alpha Glucosidase Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Lysosomal Alpha Glucosidase Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Lysosomal Alpha Glucosidase Market Size Forecast by Region (2021-2026)
12.5 Latin America Lysosomal Alpha Glucosidase Market Size Forecast (2021-2026)
12.5.1 Latin America: Lysosomal Alpha Glucosidase Sales Forecast (2021-2026)
12.5.2 Latin America: Lysosomal Alpha Glucosidase Revenue Forecast (2021-2026)
12.5.3 Latin America: Lysosomal Alpha Glucosidase Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Lysosomal Alpha Glucosidase Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Lysosomal Alpha Glucosidase Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Lysosomal Alpha Glucosidase Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Lysosomal Alpha Glucosidase Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Lysosomal Alpha Glucosidase Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Lysosomal Alpha Glucosidase Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Lysosomal Alpha Glucosidase Market Segments
Table 2. Ranking of Global Top Lysosomal Alpha Glucosidase Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Lysosomal Alpha Glucosidase Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AT-982
Table 5. Major Manufacturers of ATB-200
Table 6. Major Manufacturers of AVRRD-03
Table 7. Major Manufacturers of JR-162
Table 8. Major Manufacturers of MOSS-GAA
Table 9. Major Manufacturers of OXY-2810
Table 10. Major Manufacturers of Others
Table 11. Global Lysosomal Alpha Glucosidase Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Lysosomal Alpha Glucosidase Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Lysosomal Alpha Glucosidase Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Lysosomal Alpha Glucosidase Sales Market Share by Regions (2015-2020)
Table 15. Global Lysosomal Alpha Glucosidase Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Lysosomal Alpha Glucosidase Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Lysosomal Alpha Glucosidase Sales Share by Manufacturers (2015-2020)
Table 18. Global Lysosomal Alpha Glucosidase Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Lysosomal Alpha Glucosidase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Alpha Glucosidase as of 2019)
Table 20. Lysosomal Alpha Glucosidase Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Lysosomal Alpha Glucosidase Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Lysosomal Alpha Glucosidase Price (2015-2020) (USD/Pcs)
Table 23. Lysosomal Alpha Glucosidase Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Lysosomal Alpha Glucosidase Product Type
Table 25. Date of International Manufacturers Enter into Lysosomal Alpha Glucosidase Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Lysosomal Alpha Glucosidase Sales by Type (2015-2020) (K Pcs)
Table 28. Global Lysosomal Alpha Glucosidase Sales Share by Type (2015-2020)
Table 29. Global Lysosomal Alpha Glucosidase Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Lysosomal Alpha Glucosidase Revenue Share by Type (2015-2020)
Table 31. Lysosomal Alpha Glucosidase Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Lysosomal Alpha Glucosidase Sales by Application (2015-2020) (K Pcs)
Table 33. Global Lysosomal Alpha Glucosidase Sales Share by Application (2015-2020)
Table 34. North America Lysosomal Alpha Glucosidase Sales by Country (2015-2020) (K Pcs)
Table 35. North America Lysosomal Alpha Glucosidase Sales Market Share by Country (2015-2020)
Table 36. North America Lysosomal Alpha Glucosidase Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Lysosomal Alpha Glucosidase Revenue Market Share by Country (2015-2020)
Table 38. North America Lysosomal Alpha Glucosidase Sales by Type (2015-2020) (K Pcs)
Table 39. North America Lysosomal Alpha Glucosidase Sales Market Share by Type (2015-2020)
Table 40. North America Lysosomal Alpha Glucosidase Sales by Application (2015-2020) (K Pcs)
Table 41. North America Lysosomal Alpha Glucosidase Sales Market Share by Application (2015-2020)
Table 42. Europe Lysosomal Alpha Glucosidase Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Lysosomal Alpha Glucosidase Sales Market Share by Country (2015-2020)
Table 44. Europe Lysosomal Alpha Glucosidase Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Lysosomal Alpha Glucosidase Revenue Market Share by Country (2015-2020)
Table 46. Europe Lysosomal Alpha Glucosidase Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Lysosomal Alpha Glucosidase Sales Market Share by Type (2015-2020)
Table 48. Europe Lysosomal Alpha Glucosidase Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Lysosomal Alpha Glucosidase Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Lysosomal Alpha Glucosidase Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Lysosomal Alpha Glucosidase Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Lysosomal Alpha Glucosidase Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Lysosomal Alpha Glucosidase Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Lysosomal Alpha Glucosidase Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Lysosomal Alpha Glucosidase Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Lysosomal Alpha Glucosidase Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Lysosomal Alpha Glucosidase Sales Market Share by Application (2015-2020)
Table 58. Latin America Lysosomal Alpha Glucosidase Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Lysosomal Alpha Glucosidase Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Lysosomal Alpha Glucosidase Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Lysosomal Alpha Glucosidase Revenue Market Share by Country (2015-2020)
Table 62. Latin America Lysosomal Alpha Glucosidase Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Lysosomal Alpha Glucosidase Sales Market Share by Type (2015-2020)
Table 64. Latin America Lysosomal Alpha Glucosidase Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Lysosomal Alpha Glucosidase Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Lysosomal Alpha Glucosidase Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Lysosomal Alpha Glucosidase Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Lysosomal Alpha Glucosidase Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Lysosomal Alpha Glucosidase Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Lysosomal Alpha Glucosidase Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Lysosomal Alpha Glucosidase Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Lysosomal Alpha Glucosidase Sales Market Share by Application (2015-2020)
Table 74. Amicus Therapeutics Inc Corporation Information
Table 75. Amicus Therapeutics Inc Description and Major Businesses
Table 76. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Amicus Therapeutics Inc Product
Table 78. Amicus Therapeutics Inc Recent Development
Table 79. Audentes Therapeutics Inc Corporation Information
Table 80. Audentes Therapeutics Inc Description and Major Businesses
Table 81. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Audentes Therapeutics Inc Product
Table 83. Audentes Therapeutics Inc Recent Development
Table 84. Etubics Corp Corporation Information
Table 85. Etubics Corp Description and Major Businesses
Table 86. Etubics Corp Lysosomal Alpha Glucosidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Etubics Corp Product
Table 88. Etubics Corp Recent Development
Table 89. Genzyme Corp Corporation Information
Table 90. Genzyme Corp Description and Major Businesses
Table 91. Genzyme Corp Lysosomal Alpha Glucosidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Genzyme Corp Product
Table 93. Genzyme Corp Recent Development
Table 94. greenovation Biotech GmbH Corporation Information
Table 95. greenovation Biotech GmbH Description and Major Businesses
Table 96. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. greenovation Biotech GmbH Product
Table 98. greenovation Biotech GmbH Recent Development
Table 99. Huons Co Ltd Corporation Information
Table 100. Huons Co Ltd Description and Major Businesses
Table 101. Huons Co Ltd Lysosomal Alpha Glucosidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Huons Co Ltd Product
Table 103. Huons Co Ltd Recent Development
Table 104. JCR Pharmaceuticals Co Ltd Corporation Information
Table 105. JCR Pharmaceuticals Co Ltd Description and Major Businesses
Table 106. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. JCR Pharmaceuticals Co Ltd Product
Table 108. JCR Pharmaceuticals Co Ltd Recent Development
Table 109. Oxyrane Belgium NV Corporation Information
Table 110. Oxyrane Belgium NV Description and Major Businesses
Table 111. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Oxyrane Belgium NV Product
Table 113. Oxyrane Belgium NV Recent Development
Table 114. Pharming Group NV Corporation Information
Table 115. Pharming Group NV Description and Major Businesses
Table 116. Pharming Group NV Lysosomal Alpha Glucosidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Pharming Group NV Product
Table 118. Pharming Group NV Recent Development
Table 119. Sarepta Therapeutics Inc Corporation Information
Table 120. Sarepta Therapeutics Inc Description and Major Businesses
Table 121. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Sarepta Therapeutics Inc Product
Table 123. Sarepta Therapeutics Inc Recent Development
Table 124. Global Lysosomal Alpha Glucosidase Sales Forecast by Regions (2021-2026) (K Pcs)
Table 125. Global Lysosomal Alpha Glucosidase Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Lysosomal Alpha Glucosidase Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Lysosomal Alpha Glucosidase Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Lysosomal Alpha Glucosidase Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. North America: Lysosomal Alpha Glucosidase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Lysosomal Alpha Glucosidase Sales Forecast by Country (2021-2026) (K Pcs)
Table 131. Europe: Lysosomal Alpha Glucosidase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Lysosomal Alpha Glucosidase Sales Forecast by Region (2021-2026) (K Pcs)
Table 133. Asia Pacific: Lysosomal Alpha Glucosidase Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Lysosomal Alpha Glucosidase Sales Forecast by Country (2021-2026) (K Pcs)
Table 135. Latin America: Lysosomal Alpha Glucosidase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Lysosomal Alpha Glucosidase Sales Forecast by Country (2021-2026) (K Pcs)
Table 137. Middle East and Africa: Lysosomal Alpha Glucosidase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Lysosomal Alpha Glucosidase Players
Table 142. Lysosomal Alpha Glucosidase Customers List
Table 143. Lysosomal Alpha Glucosidase Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Lysosomal Alpha Glucosidase Product Picture
Figure 2. Global Lysosomal Alpha Glucosidase Sales Market Share by Type in 2020 & 2026
Figure 3. AT-982 Product Picture
Figure 4. ATB-200 Product Picture
Figure 5. AVRRD-03 Product Picture
Figure 6. JR-162 Product Picture
Figure 7. MOSS-GAA Product Picture
Figure 8. OXY-2810 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Lysosomal Alpha Glucosidase Sales Market Share by Application in 2020 & 2026
Figure 11. Glycogen Storage Disease
Figure 12. Pompe Disease
Figure 13. Others
Figure 14. Lysosomal Alpha Glucosidase Report Years Considered
Figure 15. Global Lysosomal Alpha Glucosidase Market Size 2015-2026 (US$ Million)
Figure 16. Global Lysosomal Alpha Glucosidase Sales 2015-2026 (K Pcs)
Figure 17. Global Lysosomal Alpha Glucosidase Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2015-2020)
Figure 19. Global Lysosomal Alpha Glucosidase Sales Market Share by Region in 2019
Figure 20. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2015-2020)
Figure 21. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region in 2019
Figure 22. Global Lysosomal Alpha Glucosidase Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Lysosomal Alpha Glucosidase Revenue in 2019
Figure 24. Lysosomal Alpha Glucosidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2015-2020)
Figure 26. Global Lysosomal Alpha Glucosidase Sales Market Share by Type in 2019
Figure 27. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2015-2020)
Figure 28. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type in 2019
Figure 29. Global Lysosomal Alpha Glucosidase Market Share by Price Range (2015-2020)
Figure 30. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2015-2020)
Figure 31. Global Lysosomal Alpha Glucosidase Sales Market Share by Application in 2019
Figure 32. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2015-2020)
Figure 33. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application in 2019
Figure 34. North America Lysosomal Alpha Glucosidase Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Lysosomal Alpha Glucosidase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Lysosomal Alpha Glucosidase Sales Market Share by Country in 2019
Figure 37. North America Lysosomal Alpha Glucosidase Revenue Market Share by Country in 2019
Figure 38. U.S. Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Lysosomal Alpha Glucosidase Market Share by Type in 2019
Figure 43. North America Lysosomal Alpha Glucosidase Market Share by Application in 2019
Figure 44. Europe Lysosomal Alpha Glucosidase Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Lysosomal Alpha Glucosidase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Lysosomal Alpha Glucosidase Sales Market Share by Country in 2019
Figure 47. Europe Lysosomal Alpha Glucosidase Revenue Market Share by Country in 2019
Figure 48. Germany Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Lysosomal Alpha Glucosidase Market Share by Type in 2019
Figure 59. Europe Lysosomal Alpha Glucosidase Market Share by Application in 2019
Figure 60. Asia Pacific Lysosomal Alpha Glucosidase Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Lysosomal Alpha Glucosidase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Lysosomal Alpha Glucosidase Sales Market Share by Region in 2019
Figure 63. Asia Pacific Lysosomal Alpha Glucosidase Revenue Market Share by Region in 2019
Figure 64. China Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Lysosomal Alpha Glucosidase Market Share by Type in 2019
Figure 87. Asia Pacific Lysosomal Alpha Glucosidase Market Share by Application in 2019
Figure 88. Latin America Lysosomal Alpha Glucosidase Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Lysosomal Alpha Glucosidase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Lysosomal Alpha Glucosidase Sales Market Share by Country in 2019
Figure 91. Latin America Lysosomal Alpha Glucosidase Revenue Market Share by Country in 2019
Figure 92. Mexico Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Lysosomal Alpha Glucosidase Market Share by Type in 2019
Figure 99. Latin America Lysosomal Alpha Glucosidase Market Share by Application in 2019
Figure 100. Middle East and Africa Lysosomal Alpha Glucosidase Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Lysosomal Alpha Glucosidase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Lysosomal Alpha Glucosidase Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Lysosomal Alpha Glucosidase Revenue Market Share by Country in 2019
Figure 104. Turkey Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Lysosomal Alpha Glucosidase Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Lysosomal Alpha Glucosidase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Lysosomal Alpha Glucosidase Market Share by Type in 2019
Figure 111. Middle East and Africa Lysosomal Alpha Glucosidase Market Share by Application in 2019
Figure 112. North America Lysosomal Alpha Glucosidase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Lysosomal Alpha Glucosidase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Lysosomal Alpha Glucosidase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Lysosomal Alpha Glucosidase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Lysosomal Alpha Glucosidase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Lysosomal Alpha Glucosidase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Lysosomal Alpha Glucosidase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Lysosomal Alpha Glucosidase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Lysosomal Alpha Glucosidase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Lysosomal Alpha Glucosidase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
αグルコシダーゼ阻害剤の世界市場（～2026年） Alpha-glucosidase is an enzyme that is inhibited by alpha-glucosidase inhibitor drugs. Alpha-glucosidase helps in absorption of carbohydrates by breaking down carbohydrates into tiny sugar molecules such as glucose. The inhibition is reversible, and competitive inhibition. Alpha-glucosidase inhibito…- リソソーム蓄積症（LSD）の世界市場（～2026年） Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Dis…
- リソソーム蓄積症（LSD）治療薬の世界市場（～2026年） Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells. The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market. Market Analysis and Insights: Glob…
- α放射体の世界市場（～2026年） Alpha emitters are the radioactive substances which decay after emitting the alpha particles. Alpha emitter radionuclide is considered to be a new approach to treat many cancer types. Alpha particles offers the definite tumor cell slaughter action causing the less damage to adjacent normal tissues t…
- αガラクトシダーゼAの世界市場（～2026年） Market Analysis and Insights: Global Alpha Galactosidase A Market The global Alpha Galactosidase A market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alpha Galactosidase A Scope and Market Size Alpha Galactosidase A marke…